Aug 23, 2019 / 12:00AM GMT
Presentation
Aug 23, 2019 / 12:00AM GMT
=====================
Corporate Participants
=====================
* Nick Freeman
Mayne Pharma Group Limited - Group CFO & Company Secretary
* Scott Anthony Richards
Mayne Pharma Group Limited - MD, CEO & Executive Director
=====================
Conference Call Participants
=====================
* David Bailey
Macquarie Research - Research Analyst
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc, Research Division - Director & Head of Healthcare in Australia and New Zealand
* John Hester
Bell Potter Securities Limited, Research Division - Senior Healthcare Equities Analyst
* Saul Hadassin
UBS Investment Bank, Research Division - Executive Director & Research Analyst
* Shane A. Storey
Wilsons Advisory and Stockbroking Limited, Research Division - Senior Analyst
* Simon Conn
Investors Mutual Limited - Senior Portfolio Manager
====
Mayne Pharma Group Ltd
(ASX:MYX)
A$
2.57
+0.18 (+7.53%)
Market Cap: 194.18 Mil
Enterprise Value: 166.94 Mil
PE Ratio: 0
PB Ratio: 0.58
GF Score: 51/100 Full Year 2019 Mayne Pharma Group Ltd Earnings Presentation Transcript
Aug 23, 2019 / 12:00AM GMT
Release Date Price:
A$10.5
(+10.53%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot